Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value (YMAB).
- Disclosed ownership: 5.8%.
- Date of event: 08 Aug 2025.
GLAZER CAPITAL, LLC - 08 Aug 2025 SCHEDULE 13G Report for Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value (YMAB)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- YMAB
- Shares outstanding
- 45,457,192 shares
- Disclosed Ownership
- 2,654,700 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 15 Aug 2025, 16:28:04 UTC
- Date of event
- 08 Aug 2025
- Next filing
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 5.8% ownership in Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value (YMAB) on 08 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Aug 2025, 16:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 5.8% | 2,654,700 | 0 | 2,654,700 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 5.8% | 2,654,700 | 0 | 2,654,700 | Paul J. Glazer | Paul J. Glazer |